Loading...
Palatin Technologies, Inc.
PTN•AMEX
HealthcareBiotechnology
$0.09
$-0.08(-44.65%)
Palatin Technologies, Inc. (PTN) Financial Performance & Statements
Review Palatin Technologies, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-7.49%
↓ 7.49%
Operating Income Growth
30.69%
↑ 30.69%
Net Income Growth
-7.97%
↓ 7.97%
Operating Cash Flow Growth
-10.71%
↓ 10.71%
Operating Margin
-6723.22%
↓ 6723.22%
Gross Margin
51.45%
↑ 51.45%
Net Profit Margin
-6665.14%
↓ 6665.14%
ROE
453.73%
↑ 453.73%
ROIC
372.34%
↑ 372.34%
Palatin Technologies, Inc. (PTN) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Palatin Technologies, Inc. stock.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $350000.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $171789.00 |
| Gross Profit | $0.00 | $0.00 | $350000.00 | -$171789.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $1.00 | |
| R&D Expenses | $3.43M | $5.74M | $4.67M | $7.16M |
| SG&A Expenses | $1.68M | $2.02M | $4.004M | $1.86M |
| Operating Expenses | $2.61M | $7.76M | $8.51M | $9.02M |
| Total Costs & Expenses | $2.61M | $7.76M | $8.69M | $9.19M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $3803.00 | $5940.00 | $3373.00 | $1254.00 |
| Depreciation & Amortization | $162309.00 | $80790.00 | $81960.00 | $171789.00 |
| EBITDA | -$2.37M | -$7.74M | -$8.17M | -$8.26M |
| EBITDA Ratio | -$23.33 | |||
| Operating Income | -$2.61M | -$7.76M | -$8.33M | -$9.19M |
| Operating Income Ratio | -$23.79 | |||
| Other Income/Expenses (Net) | $168841.00 | -$58964.00 | $75205.00 | $757450.00 |
| Income Before Tax | -$2.44M | -$7.82M | -$8.25M | -$8.44M |
| Income Before Tax Ratio | -$23.57 | |||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$2.44M | -$7.82M | -$8.25M | -$8.44M |
| Net Income Ratio | -$23.57 | |||
| EPS | -$0.12 | -$0.39 | -$0.56 | -$0.53 |
| Diluted EPS | -$0.12 | -$0.39 | -$0.56 | -$0.53 |
| Weighted Avg Shares Outstanding | $20.63M | $19.85M | $14.70M | $15.79M |
| Weighted Avg Shares Outstanding (Diluted) | $20.63M | $19.85M | $14.70M | $15.79M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan